Feb 06, 2017 08:30 AM
Feb 08, 2017 06:35 PM
|Where||Genome Campus in Hinxton, Conference|
|Contact Name||Carl Anderson|
|Add event to calendar||
Next generation sequencing has accelerated the discovery of highly penetrant causal variants in diverse primary immune deficiencies, providing insight into the non-redundant functions of the affected genes and pathways in human immunity. In parallel, the application of GWAS has been arguably most successful in immune-related traits, such that together we now have evidence of the role of genetic variation in susceptibility to various immune diseases across the prevalence spectrum. To accelerate the translation of these discoveries into the clinic, we urgently need to improve our understanding of the molecular consequences of disease-associated variants, immunological processes and drug target discovery.
This meeting will focus on recent successful stories in immune-mediated disease gene-mapping, causal variant identification in common and rare immune diseases, and efforts to understand the cellular consequences of these variants on the innate and adaptive immune system. We will highlight technological developments that promise to deliver further insight into the biology of the immune system in both health and disease, such as single cell sequencing, metagenomic sequencing and genome editing.